미국 주식 힘스 HIMS, 이 회사 뭐 하는 곳일까?

Hims & Hers Health Inc.는 2017년 샌프란시스코에서 시작된 디지털 헬스케어 기업입니다. 핵심은 간단합니다.
👉 병원 안 가고도 건강 상담부터 약 배송까지 ‘비대면으로’ 저렴하고 편리하게 해결해주는 서비스죠. 

🩺 무슨 서비스를 하길래 이렇게 인기일까?

HIMS의 핵심 비즈니스는 온라인 건강 상담 + 구독형 약 배송입니다.
건강 고민을 가진 사람들에게 맞춤형 솔루션을 제공합니다

초기에는 남성 고객을 대상으로 한 제품(Hims)으로 시작했으나, 이후 여성 고객을 위한 제품(Hers)으로 사업 영역을 확장했습니다. 이러한 브랜드 확장 전략은 회사의 성장에 중요한 역할을 했습니다.

---

🧴 원래는 ‘탈모약 회사’였다

Hims의 시작은 단순했습니다.
발기부전 치료제(예: 실데나필)와 탈모 치료제(미녹시딜, 피나스테리드)를 온라인으로 저렴하게 구독하는 서비스를 제공했죠.

초기 Hims는 탈모약과 성기능 개선제를 온라인으로 구독 형태로 제공하면서 입소문을 탔습니다.
특히 민감한 건강 문제를 조용히, 집에서 해결할 수 있다는 점이 20~30대에게 반응을 얻었죠.
이 ‘조용히 고민하는 문제’를 해결해준 접근 방식이 밀레니얼·Z세대에게 큰 호응을 얻으며 빠르게 성장했습니다

-대표 상품: 피나스테리드(탈모약), 실데나필(발기부전), 미녹시딜 외

-구독 모델로 매달 배송 → 반복 매출 구조 형성

300x250

---

그리고 드디어, 체중 감량 시장까지 접수!
2024년 이후 미국에서 GLP-1 계열 다이어트 약물(예: 위고비, 오젬픽)이 선풍적인 인기를 끌면서,
Hims도 체중 관리 서비스를 출시했습니다.
처음엔 조제 형태의 세마글루타이드를 판매했지만, FDA 가이드라인에 따라 판매를 중단해야 했죠.

그런데…

💥 “진짜 위고비 팝니다” 선언
— 노보 노디스크와 계약 체결
🧾 2025년 5월, Hims는 Wegovy(위고비) 제조사 노보 노디스크(Novo Nordisk)와의
직접 공급 계약을 체결하며 시장을 뒤흔듭니다.

이제는 비공식 조제가 아닌, 공식 브랜드 약물을 정식 유통할 수 있게 된 것입니다.
이는 단순 온라인 헬스케어가 아니라, 의료 플랫폼으로서 신뢰성을 인정받은 상징적인 사건이죠.

728x90

📈 주가 반응은?
— 계약 발표 후 하루 만에 주가 23% 급등
해당 소식이 전해진 직후, 투자자 반응은 폭발적이었습니다.

하루 만에 주가 23% 급등

시가총액 수천억 단위 증가

체중 감량 부문 연매출 전망: $7억 이상

즉, 위고비 공급은 단순히 제품군 확장이 아니라,
Hims의 비즈니스 모델과 밸류에이션 자체를 업그레이드시킨 사건이었습니다.

---

💸 HIMS의 수익 구조는?

힘스앤허스는 구독 서비스 모델을 중심으로 운영됩니다. 현재 약 200만 명의 유료 구독자를 보유하고 있으며, 이들에게 정기적인 헬스케어 제품과 원격 진료 서비스를 제공합니다. 이러한 구독 기반 모델은 안정적이고 예측 가능한 매출 흐름을 창출하는 데 큰 도움이 되고 있습니다.

넷플릭스 처럼 매달 일정 금액을 내고 구독서비스를 이용
-전체 매출의 90% 이상이 구독 모델
-사용자당 평균 월 결제액: 약 $84
-구독자 수: 240만 명 이상
-주요 서비스 분야: 탈모, 성 건강, 정신 건강, 피부, 체중 관리

민감한 문제를 조용히 해결해주던 탈모약 스타트업이,
이제는 위고비까지 유통하는 디지털 종합병원으로 진화해 실적을 올리고 있습니다.

---

[Eng ver]

Hims & Hers Health Inc. is a digital healthcare company founded in San Francisco in 2017. The core idea is simple:
👉 It offers affordable and convenient telehealth services, providing everything from consultations to medication delivery without needing to visit a doctor’s office.

---

🩺 What services make Hims so popular?

Hims’ core business is online health consultations combined with a subscription-based medication delivery model.
They provide personalized solutions for people dealing with various health concerns.

Initially, the company launched products targeting male customers (under the "Hims" brand), but later expanded to include products for women through the "Hers" brand.
This strategic brand expansion has played a significant role in the company’s growth.

---

🧴 It all started with hair loss treatments

Hims began with a simple offering:
They provided affordable subscription-based access to erectile dysfunction treatments (like sildenafil) and hair loss medications (like minoxidil and finasteride) online.

The brand gained popularity by allowing customers to discreetly address sensitive health concerns from the comfort of their homes.
This approach resonated strongly with Millennials and Gen Z, who appreciated the privacy and convenience.

• Flagship products: Finasteride (for hair loss), Sildenafil (for ED), Minoxidil, etc.
• Subscription model: Monthly deliveries → predictable recurring revenue

---

Taking on the weight loss market

After 2024, GLP-1-based weight loss drugs like Wegovy and Ozempic saw explosive demand in the U.S.
In response, Hims launched its own weight management service.

At first, they sold compounded semaglutide, but had to halt sales due to FDA guidance.

---

💥 Then came the bombshell: “We’re selling real Wegovy now”

— Deal signed with Novo Nordisk

In May 2025, Hims shook the market by signing a direct supply agreement with Novo Nordisk, the manufacturer of Wegovy.

Now, instead of offering unofficial compounded versions, Hims can officially distribute the branded medication.
This marks a symbolic moment where Hims is recognized not just as a telehealth service, but as a credible medical platform.

---

📈 How did the stock market react?

— 23% stock surge in one day

The announcement triggered a surge in investor enthusiasm:

• 23% share price increase in just one day
• Market cap rose by hundreds of millions of dollars
• Projected annual revenue from weight-loss division: $700 million+

This wasn’t just about adding a new product—it elevated Hims’ entire business model and valuation.

---

💸 What does Hims’ revenue model look like?

Hims & Hers operates primarily through a subscription-based service model.
With around 2 million paying subscribers, the company delivers healthcare products and telehealth services on a regular basis.
This model creates stable and predictable revenue streams.

Just like Netflix, users pay a monthly fee to access the service:

• Over 90% of total revenue comes from subscriptions
• Average revenue per user per month: ~$84
• Over 2.4 million subscribers
• Key focus areas: Hair loss, sexual health, mental health, skincare, and weight management

---

From a discreet hair-loss startup addressing sensitive concerns,
Hims has evolved into a full-fledged digital health platform, now even distributing Wegovy, and is achieving record-breaking results.